Page last updated: 2024-08-17

chlorisondamine and Arterial Occlusive Diseases

chlorisondamine has been researched along with Arterial Occlusive Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altavilla, D; Bazzani, C; Bigiani, A; Bitto, A; De Meo, V; Giuliani, D; Guarini, S; Messineo, F; Minutoli, L; Mioni, C; Squadrito, F; Squadrito, G; Venuti, FS	1

Other Studies

1 other study(ies) available for chlorisondamine and Arterial Occlusive Diseases

Article	Year
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock. Shock (Augusta, Ga.), 2006, Volume: 25, Issue:5 Topics: Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Chlorisondamine; Electric Stimulation; I-kappa B Proteins; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Shock; Splanchnic Circulation; Tumor Necrosis Factor-alpha; Vagus Nerve	2006

Article

Year

Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock.

Shock (Augusta, Ga.), 2006, Volume: 25, Issue:5

Topics: Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Chlorisondamine; Electric Stimulation; I-kappa B Proteins; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Shock; Splanchnic Circulation; Tumor Necrosis Factor-alpha; Vagus Nerve

2006